Kingdon Capital Management, L.L.C. Sc Pharmaceuticals Inc. Transaction History
Kingdon Capital Management, L.L.C.
- $639 Million
- Q2 2025
A detailed history of Kingdon Capital Management, L.L.C. transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Kingdon Capital Management, L.L.C. holds 659,711 shares of SCPH stock, worth $3.17 Million. This represents 0.39% of its overall portfolio holdings.
Number of Shares
659,711
Previous 1,000,000
34.03%
Holding current value
$3.17 Million
Previous $2.63 Million
4.45%
% of portfolio
0.39%
Previous 0.3%
Shares
3 transactions
Others Institutions Holding SCPH
# of Institutions
101Shares Held
37MCall Options Held
757KPut Options Held
0-
Orbimed Advisors LLC San Diego, CA6.06MShares$29.1 Million0.82% of portfolio
-
Rubric Capital Management LP New York, NY4.6MShares$22.1 Million0.4% of portfolio
-
Aigh Capital Management LLC Baltimore, MD3.87MShares$18.6 Million8.33% of portfolio
-
King Luther Capital Management Corp Fort Worth, TX3.54MShares$17 Million0.06% of portfolio
-
Morgan Stanley New York, NY2.15MShares$10.3 Million0.0% of portfolio
About scPharmaceuticals Inc.
- Ticker SCPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,402,100
- Market Cap $132M
- Description
- scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...